Status:

RECRUITING

Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis

Lead Sponsor:

Rhode Island Hospital

Conditions:

Carpometacarpal Sprain

Thumb Sprain

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb jo...

Detailed Description

Thumb carpometacarpal (CMC) osteoarthritis (OA) is one of the most common conditions treated by hand surgeons in the US. The treatment algorithm includes a stepwise strategy starting with conservative...

Eligibility Criteria

Inclusion

  • Adult patients (\> 18 years old) with a diagnosis of thumb CMC OA
  • Diagnosis of thumb CMC OA
  • History, clinical exam, and radiographic findings, as done in prior studies on this topic.
  • Subjective: thumb or wrist pain at rest or with activity, joint stiffness
  • Exam: basal joint tenderness, decreased mobility, deformity, instability
  • Radiograph: joint space narrowing, subchondral sclerosis, osteophytes, subchondral cysts, Eaton-Littler stage.
  • Failed conservative management with oral pain medication and splinting for at least 3 months.

Exclusion

  • Severe osteoarthritis (Eaton-Littler stage 4) or too large osteophytes to allow for injection into the joint space Inflammatory arthritis
  • Any concomitant hand conditions (i.e. carpal tunnel, trigger finger, etc)
  • Prior significant hand trauma related to the thumb or first CMC joint
  • Prior intervention or hand surgery
  • Patients with fibromyalgia or complex regional pain syndrome (CRPS)
  • Pregnant and breastfeeding patients will also be excluded. We also will exclude individuals attempting to conceive or who could become pregnant within 6-months of treatment.

Key Trial Info

Start Date :

August 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT05990881

Start Date

August 27 2023

End Date

July 1 2026

Last Update

November 20 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

235 Plain Street

Providence, Rhode Island, United States, 02905